Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study - Turhal, Serdar; Ahmet Bılıcı; Mükremın Uysal; Serkan Menekşe; Semih Akin; Fatih Yıldız; Merve Turan; Sema Sezgin Göksu; İsmail Beypınar; Teoman Şakalar; Mustafa Değirmenci; Di̇lek Erdem; et al. (My University, 2021)
Keywords: Medicine; Metastatic breast cancer; Exemestane; Internal medicine; Oncology; Everolimus; Hormone receptor; Progression-free survival; Breast cancer; Cancer; Gynecology; Aromatase; Chemotherapy; 1